Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete Revascularization.


Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 9 9 2020
medline: 22 6 2021
entrez: 8 9 2020
Statut: ppublish

Résumé

Prognostic impact of residual anatomic disease burden after functionally complete percutaneous coronary intervention (PCI), defined by post-PCI fractional flow reserve (FFR) >0.80 would be a clinically relevant question. The current study evaluated clinical outcomes at 2 years according to residual Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) score (RSS) in patients who underwent functionally complete revascularization. A total of 1910 patients (2095 revascularized vessels) with post-PCI FFR >0.80 were selected from the International Post-PCI FFR Registry. RSS was defined as the SYNTAX score recalculated after PCI, SYNTAX revascularization index was calculated as 100×(1-RSS/pre-PCI SYNTAX score), and post-PCI FFR was measured after completion of PCI. The primary outcome was target vessel failure (TVF; a composite of cardiac death, target vessel-related myocardial infarction, and clinically driven target vessel revascularization) at 2 years, and risk of TVF was compared according to tertile classification of RSS (0, 1-5, and >5) and post-PCI FFR (≥0.94, 0.87-0.93, and ≤0.86). After PCI, SYNTAX score was changed from 10.0 (Q1-Q3, 7.0-16.0) to 0.0 (Q1-Q3, 0.0-5.0) and FFR changed from 0.70±0.12 to 0.90±0.05. TVF at 2 years occurred in 4.9%, and patients with TVF showed higher pre-PCI SYNTAX score and lower post-PCI FFR than those without. However, there were no significant differences in SYNTAX revascularization index and RSS. The risk of TVF was not different according to tertile of RSS (log-rank Among patients who underwent functionally complete revascularization, residual anatomic disease burden assessed by RSS was not related with occurrence of TVF at 2 years. These results support the importance of functionally complete revascularization rather than angiographic complete revascularization. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT04012281.

Sections du résumé

BACKGROUND
Prognostic impact of residual anatomic disease burden after functionally complete percutaneous coronary intervention (PCI), defined by post-PCI fractional flow reserve (FFR) >0.80 would be a clinically relevant question. The current study evaluated clinical outcomes at 2 years according to residual Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) score (RSS) in patients who underwent functionally complete revascularization.
METHODS
A total of 1910 patients (2095 revascularized vessels) with post-PCI FFR >0.80 were selected from the International Post-PCI FFR Registry. RSS was defined as the SYNTAX score recalculated after PCI, SYNTAX revascularization index was calculated as 100×(1-RSS/pre-PCI SYNTAX score), and post-PCI FFR was measured after completion of PCI. The primary outcome was target vessel failure (TVF; a composite of cardiac death, target vessel-related myocardial infarction, and clinically driven target vessel revascularization) at 2 years, and risk of TVF was compared according to tertile classification of RSS (0, 1-5, and >5) and post-PCI FFR (≥0.94, 0.87-0.93, and ≤0.86).
RESULTS
After PCI, SYNTAX score was changed from 10.0 (Q1-Q3, 7.0-16.0) to 0.0 (Q1-Q3, 0.0-5.0) and FFR changed from 0.70±0.12 to 0.90±0.05. TVF at 2 years occurred in 4.9%, and patients with TVF showed higher pre-PCI SYNTAX score and lower post-PCI FFR than those without. However, there were no significant differences in SYNTAX revascularization index and RSS. The risk of TVF was not different according to tertile of RSS (log-rank
CONCLUSIONS
Among patients who underwent functionally complete revascularization, residual anatomic disease burden assessed by RSS was not related with occurrence of TVF at 2 years. These results support the importance of functionally complete revascularization rather than angiographic complete revascularization. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT04012281.

Identifiants

pubmed: 32895005
doi: 10.1161/CIRCINTERVENTIONS.120.009232
doi:

Banques de données

ClinicalTrials.gov
['NCT04012281']

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e009232

Commentaires et corrections

Type : CommentIn

Auteurs

Joo Myung Lee (JM)

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (J.M.L., K.H.C., Y.B.S., J.-Y.H.).

Doyeon Hwang (D)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Korea (D.H., B.-K.K.).

Ki Hong Choi (KH)

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (J.M.L., K.H.C., Y.B.S., J.-Y.H.).

Hyun-Jong Lee (HJ)

Department of Internal Medicine, Sejong General Hospital, Bucheon, Korea (H.-J.L.).

Young Bin Song (YB)

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (J.M.L., K.H.C., Y.B.S., J.-Y.H.).

Yun-Kyeong Cho (YK)

Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea (Y.-K.C., C.-W.N.).

Chang-Wook Nam (CW)

Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea (Y.-K.C., C.-W.N.).

Joo-Yong Hahn (JY)

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (J.M.L., K.H.C., Y.B.S., J.-Y.H.).

Eun-Seok Shin (ES)

Division of Cardiology, Ulsan Hospital, Korea (E.-S.S.).

Joon-Hyung Doh (JH)

Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea (J.-H.D.).

Masahiro Hoshino (M)

Division of Cardiovascular Medicine (M.H., R.H., Y.K., T.M., T.K.), Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Rikuta Hamaya (R)

Division of Cardiovascular Medicine (M.H., R.H., Y.K., T.M., T.K.), Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Yoshihisa Kanaji (Y)

Division of Cardiovascular Medicine (M.H., R.H., Y.K., T.M., T.K.), Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Tadashi Murai (T)

Division of Cardiovascular Medicine (M.H., R.H., Y.K., T.M., T.K.), Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Jun-Jie Zhang (JJ)

Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, China (J.-J.Z., F.Y., X.L., Z.G., S.-L.C.).

Fei Ye (F)

Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, China (J.-J.Z., F.Y., X.L., Z.G., S.-L.C.).

Xiaobo Li (X)

Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, China (J.-J.Z., F.Y., X.L., Z.G., S.-L.C.).

Zhen Ge (Z)

Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, China (J.-J.Z., F.Y., X.L., Z.G., S.-L.C.).

Shao-Liang Chen (SL)

Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, China (J.-J.Z., F.Y., X.L., Z.G., S.-L.C.).

Tsunekazu Kakuta (T)

Division of Cardiovascular Medicine (M.H., R.H., Y.K., T.M., T.K.), Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Department of Cardiology (T.K.), Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Bon-Kwon Koo (BK)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Korea (D.H., B.-K.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH